Invivyd annual operating margin
2024
2025
Invivyd Operating Margin Growth & History (IVVD)
Invivyd's operating margin was −103.99% for fiscal 2025.
View full Invivyd company overviewInvivyd annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −103.99% | +592.81 pp |
| 2024 | 2024-12-31 | −696.80% | — |
Invivyd quarterly operating margin
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −320.76% | −192.98 pp |
| Q1 2026 | 2026-03-31 | −313.85% | −164.15 pp |
| Q4 2025 | 2025-12-31 | −72.96% | +66.17 pp |
| Q3 2025 | 2025-09-30 | −83.96% | +586.05 pp |
| Q2 2025 | 2025-06-30 | −127.78% | +2047.44 pp |
| Q1 2025 | 2025-03-31 | −149.70% | — |
| Q4 2024 | 2024-12-31 | −139.14% | — |
| Q3 2024 | 2024-09-30 | −670.01% | — |
| Q2 2024 | 2024-06-30 | −2,175.22% | — |
Invivyd operating margin trends
Between the periods ended 2024-12-31 and 2025-12-31, Invivyd's operating margin increased from −696.80% to −103.99%, a change of +592.81 percentage points. The latest reported quarter, Q2 2026, shows −320.76%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Invivyd source filings ↗Community posts
Invivyd reports favorable Phase 3 tolerability results and outlines filing plans
Invivyd ($IVVD) said its investigational antibody VYD2311 met the primary and key secondary safety endpoints in LIBERTY, a randomized study involving 210 healthy adults aged 18–49. Within six days, 56.5% of antibody recipients reported an a ...
